本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

16.91
+0.23001.38%
盤後16.910.00000.00%16:40 EDT
成交量:142.87萬
成交額:2,410.12萬
市值:17.78億
市盈率:-11.68
高:17.30
開:16.64
低:16.05
收:16.68
資料載入中...
2022/09/13

重要事件披露

8-K - Current report
2022/08/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/24

重要事件披露

8-K - Current report
2022/05/11

重要事件披露

8-K - Current report
2022/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/03

SEC問詢函

CORRESP [Cover] - Correspondence
2022/02/24

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/24

重要事件披露

8-K - Current report
2022/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/05

重要事件披露

8-K - Current report
2021/12/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/12

持股變動聲明

4 - Statement of changes in beneficial ownership of securities